labor analgesia
Conditions
Interventions
Mutant gene carrier group:N/A
Wild-type gene carrier group:N/A
Sponsors
Women and Children's Hospital, School of Medicine, Xiamen university
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Aged >=18 years; pregnancy >= 37 weeks; singleton; head position; American Society of Anesthesiologists (ASA) grade I-II; BMI within 1±20% of the normal range;the puerpera who have analgesic needs after entering the delivery room are considered to be feasible for labor analgesia after evaluation by obstetricians, midwives and anesthesiologists;the puerpera was informed of the analgesic related issues and risks and signed an informed consent form.
Exclusion criteria
Exclusion criteria: Allergic or intolerant to sufentanil; multiple pregnancy; contraindications for spinal analgesia; serious or obstetric diseases (eg. heart disease, hypertension, liver and kidney dysfunction, eclampsia, amniotic infection, etc.), history of chronic pain (long-term use of systemic analgesic drugs); prostaglandin promotes cervical ripening history; smoking history; history of alcohol abuse; imported allogeneic blood or used human albumin and monoamine oxidase drugs in the past three months; Taking liver enzyme inducers or inhibitors within 1 month; missing baseline data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Consumption of sufentanil; | — |
Countries
China
Contacts
Public ContactQuanyao Chen
Women and Children's Hospital, School of Medicine, Xiamen University
Outcome results
None listed